Congressional spending plan: What’s in it for healthcare, and what isn’t
Chief Healthcare Executive December 21, 2024
McKinsey reaches $650M settlement over role in opioid crisis
Becker's Healthcare December 13, 2024
McKinsey and Co. will pay $650 million to resolve criminal and civil investigations into its work with opioid manufacturer Purdue Pharma.
The settlement resolves criminal and civil charges against the consulting firm, according to a Dec. 13 news release from the Justice Department.
According to the Justice Department, McKinsey consulted with Purdue Pharma on 75 engagements between 2004 and 2019, including a plan to “turbocharge” sales of OxyContin.
As part of the settlement, McKinsey will forfeit the $93 million it earned during its work for Purdue Pharma.
The firm will not do any work related to controlled substances for five years, as part of the settlement.
A former...
Today's Sponsors
Today's Sponsor